Patent · US Active

Compounds having muscarinic receptor antagonist and BETA2 adrenergic receptor agonist activity

US10004728B2 · kind B2 · utility

2Cited by

1References

12Claims

0Family size

Assignee

Chiesi Farmaceutici S.p.A. · IT

Inventors

Fabio Rancati · Parma, IT
Andrea Rizzi · Parma, IT
Laura Carzaniga · Parma, IT
Ian Linney · London, GB
Chris Knight · Ottawa, CA
Wolfgang Schmidt · Frankfurt, DE

Key dates

Filing date	Jan 12, 2017
Grant date	Jun 26, 2018
Priority date	—
Expiry date	Jan 12, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of formula I, defined herein, act both as muscarinic receptor antagonists and beta2 adrenergic receptor agonists and are useful for treating broncho-obstructive and inflammatory diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.